cuprizone has been researched along with Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brendel, M; Chrzanowski, U; Eckenweber, F; Fabisch, KH; Hecher, K; Hochstrasser, T; Kipp, M; Rühling, S; Sacher, C; Schmitz, C | 1 |
Acs, P; Bognar, Z; Fekete, K; Gallyas, F; Illes, Z; Kvell, K; Solti, I; Szanto, A; Talaber, G; Veto, S; Zalan, P | 1 |
2 other study(ies) available for cuprizone and Atrophy
Article | Year |
---|---|
Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.
Topics: Animals; Atrophy; Brain; Chelating Agents; Cuprizone; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.
Topics: Animals; Apoptosis; Atrophy; CD4 Antigens; CD8 Antigens; Cuprizone; Disease Models, Animal; Immunophenotyping; Lymphocyte Count; Male; Mice; Mitochondria; Mitogen-Activated Protein Kinases; Multiple Sclerosis; Phenotype; T-Lymphocyte Subsets; Thymocytes; Thymus Gland | 2015 |